Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
5.00
-0.38 (-7.06%)
At close: Mar 28, 2025, 4:00 PM
5.01
+0.01 (0.15%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Jaguar Health Employees
Jaguar Health had 49 employees as of December 31, 2023. The number of employees decreased by 11 or -18.33% compared to the previous year.
Employees
49
Change (1Y)
-11
Growth (1Y)
-18.33%
Revenue / Employee
$213,878
Profits / Employee
-$770,245
Market Cap
2.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
JAGX News
- 2 days ago - 83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - Accesswire
- 3 days ago - Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study - Accesswire
- 4 days ago - Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts - Accesswire
- 4 days ago - Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules - Accesswire
- 12 days ago - Jaguar Health, Inc. Announces Reverse Stock Split - Accesswire
- 17 days ago - Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders - Accesswire
- 4 weeks ago - Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value - Accesswire
- 5 weeks ago - Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF) - Accesswire